Diabetes therapy and cancer risk: where do we stand when treating patients?
Grace E Ching Sun1, Sangeeta R Kashyap2, Christian Nasr3
1Department of Medicine, Section of Endocrinology & Metabolism, Assistant Professor of Medicine, Louisiana State University Health Sciences Center, Shreveport gsun1@lsuhsc.edu.
Abstract:
The pathophysiology of type 2 diabetes mellitus conveys increased cancer risk, and any antidiabetic drug may alter that risk in a favorable or unfavorable way. This article discusses the links between diabetes and cancer, the different agents available for treating diabetes, and the cancer risk associated with these therapies.
Insights
Type 2 diabetes increases cancer risk. This review examines how diabetes treatments, including antidiabetic drugs, may affect cancer risk, impacting patient outcomes.
Area of Science:
- Endocrinology
- Oncology
Background:
- Type 2 diabetes mellitus pathophysiology is linked to an elevated risk of developing cancer.
- The choice of antidiabetic medication can influence cancer risk, either beneficially or detrimentally.
Purpose of the Study:
- To explore the complex relationship between diabetes and cancer.
- To review current antidiabetic agents and their associated cancer risks.
Main Methods:
- Literature review of studies investigating the links between type 2 diabetes, antidiabetic therapies, and cancer risk.
- Analysis of pharmacological actions of various antidiabetic drug classes.
Main Results:
- Specific antidiabetic drug classes may have differential effects on cancer incidence and progression.
- Understanding these associations is crucial for personalized diabetes management.
Conclusions:
- The interplay between type 2 diabetes, its treatment, and cancer risk requires careful consideration in clinical practice.
- Further research is needed to elucidate specific mechanisms and guide therapeutic choices.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Cancer Prevention
Some...
Cancer Prevention
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


